Rush University Medical Center
Chicago, IL, United States
Dr. Pincus is Professor of Medicine at Rush University, having served on faculties at Cornell, Stanford, University of Pennsylvania, Vanderbilt, and NYU. Early laboratory research included a radioimmunoassay to measure DNA antibodies as a clinical test for systemic lupus erythematosus, and genes that control experimental retrovirus infection. In 1982, he recognized severe functional declines and premature death in rheumatoid arthritis (RA), predicted most significantly by patient physical function scores and low socioeconomic status. He documented that early methotrexate and 3 mg prednisone improved RA outcomes considerably. He designed the first "add-on" clinical trial for RA patients with incomplete methotrexate responses. He developed a quantitative, standard “scientific” patient self-report MDHAQ (multidimensional health assessment questionnaire) to assess clinical status and changes in routine care. MDHAQ/RAPID3 (routine assessment of patient index data) is informative in all rheumatic diseases, without a need for different disease-specific questionnaires. MDHAQ/FAST3 (fibromyalgia assessment screening tool) provides clues to fibromyalgia that agree more than 80% with fibromyalgia criteria. A physician RheuMetric checklist records levels of inflammation, joint or organ damage, and distress seen as fibromyalgia, depression, etc. Dr. Pincus has published has published more than 450 reports, book chapters, and editorials.
Disclosure information not submitted.
Sunday, November 13, 2022
9:00 AM – 10:30 AM Eastern Time
Sunday, November 13, 2022
9:00 AM – 10:30 AM Eastern Time
